Cholesterol metabolism and noncholesterol sterol distribution in lipoproteins of Type 1 diabetes

Bibliography

• Sittiwet C, Gylling H, Hallikainen Metal.: The effect of improved glycaemic control on cholesterol metabolism and non-cholesterol sterol distribution in Type 1 diabetic patients. Atherosclerosis 194, 465–472 (2007).
   Google Scholar
• Gylling H, Miettinen TA: Cholesterol absorption, synthesis and LDL metabolism in NIDDM. Diabetes Care 20, 90–95 (1997).
   Google Scholar
• Rajaratnam RA, Gylling H, Miettinen TA: Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 21, 1650–1655 (2001).
   Google Scholar
• Miettinen TA, Gylling H; Subgroup analysis of Scandinavian Simvastatin Survival Study (4S): Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment. Clin. Chim. Acta 379, 53–58 (2007).
   Google Scholar
• Miettinen TA, Gylling H, Strandberg T, Sarna S; for the Finnish 4S Investigators: Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Br. Med. J. 316, 1127–1130 (1998).
   Google Scholar
• Miettinen TA, Strandberg TE, Gylling H; for the Finnish Investigators of the Scandinavian Simvastatin Survival Study Group: Non-cholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Relation to basal serum cholestanol. Arterioscler. Thromb. Vasc. Biol. 20, 1340–1346 (2000).
   Google Scholar
• Gylling H, Miettinen TA: Cholesterol absorption and lipoprotein metabolism in Type II diabetes mellitus without and with coronary artery disease. Atherosclerosis 126, 325–332 (1996).
   Google Scholar
• Deckert T, Poulsen JE, Larsen M: Prognosis of diabetics with diabetes onset before the age of 31. 11 factors influencing the prognosis. Diabetologia 14, 371–377 (1979).
   Google Scholar
• Laing SP, Swerdlow AJ, Slater SD et al.: Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 14, 371–377 (2003).
   Google Scholar
• Lahdenpera S, Syvanne M, Kahri J, Taskinen M-R: Regulation of low density lipoprotein particle size and distribution in NIDDM and coronary artery disease: importance of serum triglycerides. Diabetologia 39, 453–461 (1996).
   Google Scholar
• Axelsen M, Smith U, Eriksson JW, Taskinen MR, Jansson PA: Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with Type 2 diabetes. Ann. Intern. Med. 131, 27–31 (1999).
   Google Scholar
• Adiels M, Borén J, Caslake MJ et al.: Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 25, 1697–1703 (2005).
   Google Scholar
• Miettinen TA, Gylling H, Tuominen J, Simonen P, Koivisto V: Low synthesis and high absorption of cholesterol characterize Type 1 diabetes. Diabetes Care 27(1), 53–58 (2004).
   Google Scholar
• Jãrvisalo M, Raitakari O, Gylling H, Miettinen TA: Cholesterol absorption and synthesis in children with Type 1 diabetes. Diabetes Care 29, 2300–2304 (2006).
   Google Scholar
• Simonen PP, Gylling H, Miettinen TA: The distribution of squalene and noncholesterol sterols in lipoproteins in Type 2 diabetes. Atherosclerosis 194(1), 222–229 (2006).
   Google Scholar
• Prince CT, Becker DJ, Costacou T, Miller RG, Orchard TJ: Changes in glycaemic control and risk of coronary artery disease in Type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 50, 2280–2288 (2007).
   Google Scholar
• Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299–308 (2007).
   Google Scholar
• Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298, 309–316 (2007).
   Google Scholar
• Altmann SW, Davis HR Jr, Zhu LJ et al.: Niemann–Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201–1204 (2004).
   Google Scholar
• Davis HR Jr, Zhu LJ, Hoos LM et al.: Niemann–Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of wholebody cholesterol homeostasis. J. Biol. Chem. 279, 33586–33592 (2004).
   Google Scholar
• Lally S, Tan CY, Owens D, Tomkin GH: Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in Type 2 diabetes: the role of Niemann Pick C1-like 1, ATP binding cassette transporters ABCG5 and G8 and microsomal triglyceride transfer protein Diabetologia 49, 1008–1016 (2006).
   Google Scholar
• Temel RE, Tang W, Ma Y et al.: Hepatic Niemann–Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 117, 1968–1978 (2007).
   Google Scholar
• Berge KE, Tian H, Graf GA et al.: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290, 1771–1775 (2000).
   Google Scholar
• Graf GA, Yu L, Li WP et al.: ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary excretion. J. Biol. Chem. 278, 48275–48282 (2003).
   Google Scholar
• Dane-Stewart CA, Watts GF, Barrett PH et al.: Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without Type 2 diabetes mellitus. Clin. Endocrinol. (Oxf.) 58, 415–420 (2003).
   Google Scholar
• Phillips C, Madigan C, Owens D, Collins P, Tomkin GH: Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes? Int. J. Exp. Diabetes Res. 3, 171–178 (2002).
   Google Scholar
• Feingold KR, Wilson DE, Wood LC, Kwong LK, Moser AH, Grunfeld C: Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine. Metabolism 43, 450–454 (1994).
   Google Scholar
• Gleeson A, Owens D, Collins P, Johnson A, Tomkin GH: The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model. Int. J. Exp. Diab. Res. 1, 203–210 (2000).
   Google Scholar
• Federico LM, Naples M, Taylor D, Adeli K: Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory elementbinding protein-1c in the fructose-fed hamster intestine. Diabetes 55, 1316–1326 (2006).
   Google Scholar
• Stettler C, Allemann S, Jüni P et al.: Glycemic control and macrovascular disease in Types 1 and 2 diabetes mellitus: metaanalysis of randomized trials. Am. Heart J. 152, 27–38 (2006).
   Google Scholar
• Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22, 99–111 (1999).
   Google Scholar
• Cleary PA, Orchard TJ, Genuth S et al.: DCCT/EDIC Research Group: The effect of intensive glycemic treatment on coronary artery calcification in Type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55, 3556–3565 (2006).
   Google Scholar
• Orchard TJ, Olson JC, Erbey JR et al.: Insulin resistance-related factors, but not glycemia, predict coronary artery disease in Type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26, 1374–1379 (2003).
   Google Scholar
• Proctor SD, Mamo JC: Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. Vasc. Biol. 23, 1595–1600 (2003).
   Google Scholar
• Proctor SD, Vine DF, Mamo JC: Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler. Thromb. Vasc. Biol. 24, 2162–2167 (2004).
   Google Scholar
• Karpe F, Steiner G, Uffelman K, Olivercrona T, Hamsten A: Postprandial lipoproteins and the progression of coronary atherosclerosis. Atherosclerosis 106, 83–97 (1994).
   Google Scholar
• Vakkilainen J, Steiner G, Ansquer JC et al.; DAIS Group: Relationships between lowdensity lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 107, 1733–1737 (2003).
   Google Scholar
• Matthan NR, Lichtenstein AH: Approaches to measuring cholesterol absorption in humans. Atherosclerosis 174, 197–205 (2004).
   Google Scholar
• Kissebah AH, Alfarsi S, Evans DJ, Adams PW: Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 71, 655–667 (1983).
   Google Scholar
• Howard BV, Abbott WG, Beltz WF et al.: Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulindependent diabetes. Metabolism 36, 870–877 (1987).
   Google Scholar
• Deegan P, Owens D, Collins P, Johnson A, Tomkin GH: The influence of low density lipoprotein composition on its metabolism in non-insulin-dependent diabetes mellitus. Metabolism 48, 1–8 (1999).
   Google Scholar
• Koba S, Hirano T, Ito Y et al.: Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis 189, 206–214 (2006).
   Google Scholar
• Miettinen TA, Gylling H, Tuominen J, Simonen P, Koivisto V: Low synthesis and high absorption of cholesterol characterize Type 1 diabetes. Diabetes Care 27, 53–58 (2004).
   Google Scholar
• Miettinen TA, Gylling H, Strandberg T, Sarna S: Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. Br. Med. J. 316, 1127–1130 (1998).
   Google Scholar
• Sutherland WHF, Williams MJA, Nye ER, Restieaux NJ, de Jong SA, Walker HL: Associations of plasma noncholesterol sterol levels with severity of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 8, 386–391 (1998).
   Google Scholar
• Miettinen TA, Railo M, Lepãntalo M, Gylling H: Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J. Am. Coll. Cardiol. 45, 1794–1801 (2005).
   Google Scholar